TAVI Index Procedure: The Value of Valve Optimisation on Long-term Outcomes and Lifetime Management

Date: Wednesday, 9 April 2025
Time: 17:05 CEST | 11:05 EDT

Chair: Rui Teles, Carnaxide, PT
Panel: James Cockburn, Brighton, UK; Birgid Gonska, Bad Nauheim, DE; Vlasis Ninios, Thessaloniki, GR
Case Operator: Won-Keun Kim, University of Giessen & Marburg, Giessen, DE

Overview

Join leading experts for this hands-on symposium focused on optimising TAVI for long-term patient outcomes. This interactive session dives into critical techniques for lesion preparation, valve positioning and post-dilation, essential for managing larger annuli patients and ensuring lifetime procedural success.

Experience a live case demonstration and gain first-hand expertise from an experienced operator, showcasing how precise procedural strategies can impact valve durability, functionality and patient prognosis. Engage in real-time discussions, ask questions and refine your TAVI index procedure approach with specialist insights.

Agenda

• Welcome and Introduction – Rui Teles, Carnaxide, PT
• TAVI Procedure Optimisation: Lessons From the ACURATE IDE Study – James Cockburn, Brighton, UK
• Enhancing TAVI Outcomes: Precise Valve Placement and Implantation – Birgid Gonska, Bad Nauheim, DE
• Implications of Index Procedure Outcomes on Lifetime Patient Management – Vlasis Ninios, Thessaloniki, GR
• Case in Focus: TAVI for Larger Annuli Patients – Won-Keun Kim, Giessen, DE
• Panel Discussion and Q&A – All

Learning objectives

• Recall the critical steps in lesion preparation and on post dilation to optimise valve implantation when needed
• Recognise the technical considerations in precise valve positioning and deployment for larger annuli patients
• Explore the long-term implications of index procedure optimisation on patient management and outcomes
• Engage with an expert operator through a live case demonstration and interactive discussion

This symposium is supported by an unrestricted educational grant from Boston Scientific.

*TAVI Index Procedure: The Value of Valve Optimisation on Long-term Outcomes and Lifetime Management has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 CME point, equating to 1 hour of learning. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.

Optimising Large-Bore Venous Closure: PerQseal® Elite in Real-World Practice

Date: Wednesday, 9 April 2025
Time: 14:05 CEST | 08:05 EDT

Chair: Vasileios Panoulas, London, UK
Panel: Rutger-Jan Nuis, Rotterdam, NL; Mohamed Abdel-Wahab, Leipzig, DE

Agenda

• Introduction and Session Objectives – Vasileios Panoulas
• The Evolving Landscape of Large-Bore Venous Closure – Vasileios Panoulas
• PerQseal® Elite: Innovation and Clinical Evidence – Rutger-Jan Nuis
• Case-Based Discussion: Practical Tips for PerQseal® Elite – Mohamed Abdel-Wahab
• Closing Remarks and Q&A – All Faculty

Learning objectives

• Understand the advancements in large-bore venous closure
• Discuss best practices for PerQseal® Elite in clinical scenarios
• Review future directions in venous closure technology

This breakout is supported by Vivasure Medical.

Optimising the Therapeutic Management of Women With Aortic Stenosis: Insights and Implications From Emerging Data

Date: Thursday, 10 April 2025
Time: 17:05 CEST | 11:05 EDT

Panel: Roxana Mehran, New York, US; Sinjini Biswas, Melbourne, AU; Marta Kaluzna-Oleksy, Poznan, PL; Zainab Dakhil, Baghdad, IQ

Overview

This breakout session explores sex-specific challenges in diagnosing and managing aortic stenosis in female patients, highlighting anatomical and clinical differences, procedural risks and emerging trial data to inform tailored treatment strategies.

Agenda

• Peri- and Post-procedural Considerations for Female Patients – Sinjini Biswas
• Women Undergoing Aortic Valve Replacement – Marta Kaluzna-Oleksy
• Asymptomatic AS Patients and the EARLY TAVR Trial – Zainab Dakhil
• Panel Discussion and Q&A – All

Learning objectives

• Understand the clinical and anatomical differences in female patients with aortic stenosis
• Explore sex-specific challenges in peri- and post-procedural care for female patients
• Analyse key findings from recent trials in female-specific valve replacement and Aortic Stenosis treatment
• Examine the need for sex-specific guidelines in aortic stenosis diagnosis and treatment

This breakout is in partnership with Women as One

Management of Degenerative MR With TEER: An Evidence-based Guide

Date: Saturday, 12 April 2025
Time: 19:05 CEST | 13:05 EDT

Chair: Tarun Chakravarty, Los Angeles, US
Panel: Firas Zahr, Portland, US; Tom Cahill, Oxford, UK

Overview

Join this interactive symposium to explore patient selection, device differentiation and key technical strategies for transcatheter edge-to-edge repair (TEER) in degenerative mitral regurgitation (DMR). Leading experts will dive into the growing unmet need for DMR treatment in the US, unpack the latest clinical data and share procedural insights through real-world case discussions.

Expect practical takeaways on device-specific features, technical precision and long-term clinical outcomes, all designed to elevate your approach to TEER. Don't miss this opportunity to engage with experts and refine your decision-making in DMR treatment.

Agenda

• Welcome and Introduction – Tarun Chakravarty
• Transcatheter Repair: Selection in Degenerative MR – Tarun Chakravarty
• Making Evidence-based Decisions in TEER – Insights From Recent Clinical Data – Firas Zahr
• Technical Considerations for TEER in DMR Patients – Tom Cahill
• Discussion and Q&A – All

Learning objectives

• Identify suitable patients for transcatheter repair over other treatments
• Recall long-term clinical outcomes for TEER in patients with DMR
• Select TEER devices based on design features and clinical data
• Review TEER implantation techniques

This symposium is supported by an unrestricted educational grant from Edwards Lifesciences.

*This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Radcliffe Medical Education. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

PeerPoint Medical Education Institute designates the live and enduring format for this educational activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Live activity date: April 12, 2025
Enduring activity dates: April 30, 2025 – April 30, 2026